Metagenics clarifying annoucement
Released
Released
Announcement PDF
Metagenics clarifying announcement
1st December 2023 Brisbane, Australia: The Calmer Co. International Limited
(ASX:CCO), provides the following additional information related to the
announcement of 29th November 2023 related to Metagenics USA launches
MetaSleep powered by Kavaton
• The contract for supply of kavaton is between Network Nutrition and Metagenics
USA
• Any sales to Metagenics from Network Nutrition will fall under the distribution
agreement CCO has in place with Network Nutrition (announced on 22nd July
2022).
• Product sold to Metagenics will be purchased by Network Nutirtion from CCO
and then onsold by them, and any revenue to CCO will fall under the Network
Nutrition contract that is already in place.
• The total future sales under the contract are not quantifiable at this stage.
This announcement has been approved by the company secretary
ends
Forward Looking Statements
This ASX release includes certain forward-looking statements that are based on information and
assumptions known to date and are subject to various risks and uncertainties. Actual results,
performance or achievements could be significantly different from those expressed in, or implied
by, these forward-looking statements. Such forward-looking statements are not guarantees of
future performance and involve known and unknown risks, uncertainties and other factors, many
of which are beyond the control of Fiji Kava. These factors may cause actual results to differ
materially from those expressed in the statements contained in this announcement.
Share your feedback
Discover